Linked from

The 49 pages that link to Drug metabolism, each with the reason it gives.

• StereochemistryRelated: Metabolic enzymes can process stereoisomers at different rates or through different pathways.

• BioavailabilityRelated: Metabolism can inactivate drug before systemic entry or convert a prodrug into its active form.

• Adverse drug reactionRelated: Metabolism can inactivate a drug or produce compounds that contribute to harmful responses.

• Drug discoveryRelated: Metabolism affects exposure, duration of action, and the formation of harmful products.

• Enzyme catalysisRelated: Enzyme catalysis determines how many medicines are activated, inactivated, or cleared.

• BiochemistryRelated: It links biochemical pathways to drug effects, duration, and toxicity.

• High-performance liquid chromatographyRelated: HPLC separates drug metabolites in biological samples before their identification or quantification.

• IsomerismRelated: Metabolic enzymes can distinguish isomers and transform them at different rates.

• Forensic toxicologyRelated: Metabolites can reveal exposure after the parent drug has declined or disappeared.

• AntihistamineRelated: Metabolism affects how long particular antihistamines act and how they interact with other medicines.

• Medicinal chemistryRelated: Metabolic stability and metabolites can determine whether an optimized structure is viable.

• Chemical reactivityRelated: Molecular reactivity helps determine how medicines are transformed in the body.

• Drug toleranceRelated: Enzyme induction can accelerate drug breakdown and contribute to tolerance.

• Drug allergyRelated: Metabolism can create reactive drug products that participate in immune recognition.

• Combination drugRelated: Metabolic competition or inhibition can change exposure to ingredients in the same product.

• Drug absorptionRelated: Metabolism can occur before or after systemic entry, but is distinct from absorption itself.

• Second-generation antihistamineRelated: Metabolism and interactions can alter exposure and adverse-effect risks for particular agents.

• RisperidoneRelated: CYP2D6 converts risperidone into paliperidone, its active metabolite.

• AcetazolamideRelated: Acetazolamide is largely excreted unchanged, so renal function strongly influences exposure.

• Organic reactionRelated: Organic transformations determine how medicines are activated, modified, or cleared.

• Structural isomerRelated: Drug isomers can be processed differently because enzymes recognize molecular structure.

• AtomoxetineRelated: Metabolism by CYP2D6 affects dosing considerations and the risk of elevated atomoxetine exposure.

• LoratadineRelated: Metabolism converts loratadine into active desloratadine.

• TautomerRelated: Tautomeric forms can differ in enzyme recognition, solubility, and membrane passage.

• CurcuminRelated: Rapid metabolism contributes to low circulating levels of orally consumed curcumin.

• DesloratadineRelated: Metabolism and liver function can affect desloratadine exposure and dosing considerations.

• BerberineRelated: Berberine can alter drug-metabolizing enzymes, creating potential interactions with medicines.

• ErgotamineRelated: Metabolism and interactions influence ergotamine exposure and toxicity.

• NitazoxanideRelated: Rapid conversion to tizoxanide shapes nitazoxanide’s exposure after oral administration.

• Enzymes and CoenzymesRelated: Enzyme activity determines how many medicines are activated, altered, or cleared.

• Medicine (drug or remedy)Related: Metabolism can deactivate a medicine or convert it into an active form.

• PiroxicamRelated: Liver metabolism contributes to piroxicam clearance and can affect its exposure.